Compliance and Anti-Fraud Committee

Presentation

The Compliance and Anti-Fraud Committee is committed to the highest standards of legal and ethical compliance, in accordance with the principles of integrity, objectivity, proportionality, impartiality and honesty in the performance of its functions.

To this end, IRBLleida promotes an institutional culture aimed at preventing, detecting and correcting any irregular, fraudulent conduct or conduct contrary to current regulations, as well as strengthening the principles of good governance, transparency and sound administration.

IRBLleida adopts a zero-tolerance policy towards fraud and has an internal control system designed to prevent and detect, as far as possible, any fraudulent or irregular conduct and, where appropriate, to correct its consequences. This commitment is set out in IRBLleida's Anti-Fraud Plan and in the actions promoted by the Compliance and Anti-Fraud Committee.

Likewise, IRBLleida promotes the training, information and awareness-raising measures necessary to ensure that all staff are aware of and assume this institutional commitment.

Functions

To periodically assess the risk of fraud and ensure the existence of an effective internal control system to prevent and detect possible irregularities.
To define, propose and promote the measures necessary to prevent, detect, correct and pursue possible attempts of fraud, conflicts of interest or other regulatory breaches.
To manage, in accordance with the applicable internal procedures, communications relating to possible fraud, conflicts of interest or other breaches of current regulations.
To analyse the facts reported or detected and, where appropriate, issue recommendations or propose corrective and preventive measures.
To promote the continuous improvement of the regulatory compliance system, institutional integrity, ethical management and application of the principles of good governance.
To contribute to the dissemination of the Anti-Fraud Plan and IRBLleida's internal legal and ethical compliance policies.

Members

Eva López Truco, Manager
Carme Peirau Gabarell, Quality technician
Alicia Sánchez de la Torre, Head of the Clinical Trials Unit
Joaquín Bonelli Blasco, Head of the Projects and Innovation Department
Oriol Gasa Falcon, Innovation Technician
Lluïsa Cortés Gomis, International Staff Recruitment Office Technician
Albert Dalmases París, Responsible of the Accounting and Finance Department
Maria Ruiz Miró, Head of the Biobank and Coordinator of the Scientific and Technical Services
Elena Moscatel Mendelsohn, Head of the People and Legal Department and Compliance Officer
Sara Palau Camarero, Responsible of the People and Legal Department
Josep Maria Bosch Pons, Responsible of the Fundraising Department
Meritxell Soria Yenez, Responsible of the Communication Department
José Manuel Valdivielso Revilla, Researcher